• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Emergent BioSolutions

Emergent BioSolutions
Manufacturing

Emergent lands $62.4M upgrade to botulism antitoxin supply pact

A little less than a year after topping up its medical countermeasure contracts with Emergent BioSolutions, the federal government is back for more.
Fraiser Kansteiner Jun 26, 2025 10:30am
mAb antibody monoclonal antibody

Syngene to pay $37M for Emergent's Baltimore biologics plant

Mar 10, 2025 3:45pm
Emergent BioSolutions

JPM25: Recovering Emergent inks deal for opioid overdose spray

Jan 15, 2025 7:41pm
Bavarian Nordic

NIH study shows mpox shot elicits immune response in teens

Oct 17, 2024 11:17am
Emergent BioSolutions

Emergent BioSolutions' mpox preparedness orders reach $400M

Sep 25, 2024 1:06pm
Emergent BioSolutions

Emergent's smallpox vaccine wins FDA approval for mpox

Aug 30, 2024 11:23am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings